Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study.

ABSTRACT:

SUBMITTER: Higue J 

PROVIDER: S-EPMC12371059 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature